Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
PLoS One. 2020 Dec 18;15(12):e0243810. doi: 10.1371/journal.pone.0243810. eCollection 2020.
There are limited contemporary data on the influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction (STEMI).
To assess the influence of insurance status on STEMI outcomes.
Adult (>18 years) STEMI admissions were identified using the National Inpatient Sample database (2000-2017). Expected primary payer was classified into Medicare, Medicaid, private, uninsured and others. Outcomes of interest included in-hospital mortality, use of coronary angiography and percutaneous coronary intervention (PCI), hospitalization costs, hospital length of stay and discharge disposition.
Of the 4,310,703 STEMI admissions, Medicare, Medicaid, private, uninsured and other insurances were noted in 49.0%, 6.3%, 34.4%, 7.2% and 3.1%, respectively. Compared to the others, the Medicare cohort was older (75 vs. 53-57 years), more often female (46% vs. 20-36%), of white race, and with higher comorbidity (all p<0.001). The Medicare and Medicaid population had higher rates of cardiogenic shock and cardiac arrest. The Medicare cohort had higher in-hospital mortality (14.2%) compared to the other groups (4.1-6.7%), p<0.001. In a multivariable analysis (Medicare referent), in-hospital mortality was higher in uninsured (adjusted odds ratio (aOR) 1.14 [95% confidence interval {CI} 1.11-1.16]), and lower in Medicaid (aOR 0.96 [95% CI 0.94-0.99]; p = 0.002), privately insured (aOR 0.73 [95% CI 0.72-0.75]) and other insurance (aOR 0.91 [95% CI 0.88-0.94]); all p<0.001. Coronary angiography (60% vs. 77-82%) and PCI (45% vs. 63-70%) were used less frequently in the Medicare population compared to others. The Medicare and Medicaid populations had longer lengths of hospital stay, and the Medicare population had the lowest hospitalization costs and fewer discharges to home.
Compared to other types of primary payers, STEMI admissions with Medicare insurance had lower use of coronary angiography and PCI, and higher in-hospital mortality.
目前关于主要支付方身份对 ST 段抬高型心肌梗死(STEMI)管理和结局的影响,仅有有限的当代数据。
评估保险身份对 STEMI 结局的影响。
使用国家住院患者样本数据库(2000-2017 年)确定成年(>18 岁)STEMI 入院患者。预期主要支付方分为医疗保险、医疗补助、私人保险、无保险和其他。研究的主要结局包括住院死亡率、冠状动脉造影和经皮冠状动脉介入治疗(PCI)的使用、住院费用、住院时间和出院去向。
在 4310703 例 STEMI 入院患者中,医疗保险、医疗补助、私人保险、无保险和其他保险的占比分别为 49.0%、6.3%、34.4%、7.2%和 3.1%。与其他组相比,医疗保险组年龄更大(75 岁 vs. 53-57 岁),女性更多(46% vs. 20-36%),为白人,合并症更多(均<0.001)。医疗保险和医疗补助人群的心源性休克和心脏骤停发生率更高。医疗保险组的住院死亡率(14.2%)高于其他组(4.1-6.7%),p<0.001。多变量分析(以医疗保险为参照)显示,无保险者的住院死亡率更高(校正比值比[aOR]1.14[95%置信区间{CI}1.11-1.16]),医疗补助者较低(aOR 0.96[95%CI 0.94-0.99];p=0.002),私人保险者(aOR 0.73[95%CI 0.72-0.75])和其他保险者(aOR 0.91[95%CI 0.88-0.94])较低;均<0.001。与其他组相比,医疗保险组的冠状动脉造影(60% vs. 77-82%)和 PCI(45% vs. 63-70%)使用率较低。医疗保险和医疗补助人群的住院时间更长,医疗保险人群的住院费用最低,出院回家的比例最低。
与其他类型的主要支付方相比,医疗保险覆盖的 STEMI 入院患者的冠状动脉造影和 PCI 使用率较低,住院死亡率较高。